Related Experiment Videos
The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine
The Journal of Allergy and Clinical Immunology
|May 1, 1984
Summary
This study details a hypocomplementemic urticarial-vasculitis syndrome (HUVS) case, highlighting the urticaria-to-purpura spectrum. Hydroxychloroquine effectively treated both symptoms and serologic markers in this patient.
Area of Science:
- Immunodermatology
- Rheumatology
- Nephrology
Background:
- Hypocomplementemic urticarial-vasculitis syndrome (HUVS) is a rare autoimmune disorder.
- It is characterized by recurrent urticarial lesions, hypocomplementemia, and potential systemic involvement.
- Understanding the clinical spectrum and immunological underpinnings is crucial for effective management.
Observation:
- The case presented illustrates a clear continuum between urticarial and purpuric skin lesions, a hallmark of HUVS.
- Leukocytoclastic vasculitis was evident in skin biopsies of both urticarial and purpuric lesions.
- Immunofluorescence revealed characteristic granular deposition of C3 and C1q in the basement membrane and immune complex deposition in postcapillary venules.
Findings:
- Precipitating antibodies against C1q (C1q-P) were detected in the patient's serum, specifically within the IgG fraction.
- Low levels of total hemolytic complement activity and C1q were observed.
- Skin biopsies confirmed leukocytoclastic vasculitis with immune complex deposition.
Implications:
- This case reinforces the diagnostic criteria for HUVS and emphasizes the urticaria-purpura spectrum.
- The findings support the role of immune complex deposition involving C3 and C1q in the pathogenesis of HUVS.
- Hydroxychloroquine demonstrated significant efficacy in managing both the clinical symptoms and serologic abnormalities, suggesting it as a potential therapeutic option for HUVS.